Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.

NCT05397769 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Nasopharyngeal Carcinoma
Envafolimab
Induction Chemotherapy
PD-L1

Interventions

DRUG: Envafolimab Plus Chemoradiotherapy

Sponsor

Sun Yat-sen University